skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE)AND RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND DRUG-RESISTANT HIV-1 VARIANT

Abstract

No abstract prepared.

Authors:
; ; ; ; ; ; ; ;
Publication Date:
Research Org.:
Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source
Sponsoring Org.:
DOE/OFFICE OF SCIENCE
OSTI Identifier:
884348
Report Number(s):
BNL-76245-2005-JA
TRN: US200615%%913
DOE Contract Number:  
DE-AC02-98CH10886
Resource Type:
Journal Article
Journal Name:
BIOCHEMISTRY
Additional Journal Information:
Journal Volume: 44
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; DESIGN; BIOCHEMISTRY; BNL; national synchrotron light source

Citation Formats

DAS, K, CLARK, A, LEWI, P, HEERES, J, DE JONGE, M, KOYMANS, L, VINKERS, H, DAEYAERT, F, LUDOVICI, D, and ET AL. ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE)AND RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND DRUG-RESISTANT HIV-1 VARIANT. United States: N. p., 2004. Web. doi:10.1021/jm030558s.
DAS, K, CLARK, A, LEWI, P, HEERES, J, DE JONGE, M, KOYMANS, L, VINKERS, H, DAEYAERT, F, LUDOVICI, D, & ET AL. ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE)AND RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND DRUG-RESISTANT HIV-1 VARIANT. United States. https://doi.org/10.1021/jm030558s
DAS, K, CLARK, A, LEWI, P, HEERES, J, DE JONGE, M, KOYMANS, L, VINKERS, H, DAEYAERT, F, LUDOVICI, D, and ET AL. 2004. "ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE)AND RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND DRUG-RESISTANT HIV-1 VARIANT". United States. https://doi.org/10.1021/jm030558s.
@article{osti_884348,
title = {ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE)AND RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND DRUG-RESISTANT HIV-1 VARIANT},
author = {DAS, K and CLARK, A and LEWI, P and HEERES, J and DE JONGE, M and KOYMANS, L and VINKERS, H and DAEYAERT, F and LUDOVICI, D and ET AL.},
abstractNote = {No abstract prepared.},
doi = {10.1021/jm030558s},
url = {https://www.osti.gov/biblio/884348}, journal = {BIOCHEMISTRY},
number = ,
volume = 44,
place = {United States},
year = {2004},
month = {1}
}